Identification of Salmonella Pathogenicity Island-2 Type III Secretion System Effectors Involved in Intramacrophage Replication of S. enterica Serovar Typhimurium: Implications for Rational Vaccine Design

The Salmonella Kinase SteC Targets the MAP Kinase MEK to Regulate the Host Actin Cytoskeleton

(2012) Charlotte Odendall et al.   Cell Host & Microbe

Type III effector-mediated processes inSalmonellainfection

(2012) Joris van der Heijden et al.   Future Microbiology

Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens

(2012) Wael Abdel Halim Hegazy et al.   INFECTION AND IMMUNITY

SrfJ, a Salmonella Type III Secretion System Effector Regulated by PhoP, RcsB, and IolR

(2012) M. Cordero-Alba et al.   JOURNAL OF BACTERIOLOGY

Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors

(2012) R. Figueira et al.   MICROBIOLOGY-SGM

The Salmonella Deubiquitinase SseL Inhibits Selective Autophagy of Cytosolic Aggregates

(2012) Francisco S. Mesquita et al.   PLoS Pathogens

Salmonella Phage ST64B Encodes a Member of the SseK/NleB Effector Family

(2011) Nat F. Brown et al.   PLoS One

A comprehensive study of the contribution ofSalmonella entericaserovar Typhimurium SPI2 effectors to bacterial colonization, survival, and replication in typhoid fever, macrophage, and epithelial cell infection models

(2011) Michelle M.C. Buckner et al.   Virulence

Efficacy of Intracellular Activated Promoters for Generation of Salmonella-Based Vaccines

(2010) X. Xu et al.   INFECTION AND IMMUNITY

Discovery of Novel Secreted Virulence Factors fromSalmonella entericaSerovar Typhimurium by Proteomic Analysis of Culture Supernatants

(2010) George S. Niemann et al.   INFECTION AND IMMUNITY

Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2

(2010) C. G. Forest et al.   MICROBIOLOGY-SGM

A Randomised Trial Evaluating the Safety and Immunogenicity of the Novel Single Oral Dose Typhoid Vaccine M01ZH09 in Healthy Vietnamese Children

(2010) Tran Tinh Hien et al.   PLoS One

Dynamics of intracellular bacterial replication at the single cell level

(2010) Sophie Helaine et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7×1010 colony-forming units

(2010) C.E. Lyon et al.   VACCINE

The Virulence Protein SopD2 Regulates Membrane Dynamics of Salmonella-Containing Vacuoles

(2010) Nina Schroeder et al.   PLoS Pathogens

Salmonella enterica serovar Typhi live vector vaccines finally come of age

(2009) James E Galen et al.   IMMUNOLOGY AND CELL BIOLOGY

The Salmonella SPI2 Effector SseI Mediates Long-Term Systemic Infection by Modulating Host Cell Migration

(2009) Laura M. McLaughlin et al.   PLoS Pathogens

Identification ofSalmonellaSPI-2 secretion system components required for SpvB-mediated cytotoxicity in macrophages and virulence in mice

(2008) Sara H. Browne et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Functional Analysis of the Salmonella Pathogenicity Island 2-Mediated Inhibition of Antigen Presentation in Dendritic Cells

(2008) S. Halici et al.   INFECTION AND IMMUNITY

The Salmonella SPI-2 effector SseJ exhibits eukaryotic activator-dependent phospholipase A and glycerophospholipid : cholesterol acyltransferase activity

(2008) N. S. Lossi et al.   MICROBIOLOGY-SGM